IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 276-300 out of 1253.

<< < 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 > >>

Public Release: 20-Oct-2015
Journal of Clinical Investigation
Histone deacetylase 6 inhibition enhances oncolytic viral therapy
A new study in the Journal of Clinical Investigation indicates that inhibition of histone deaceteylase 6 improves the ability of oncolytic herpes simplex virus type 1 to kill glioma cells.
NIH/National Cancer Institute

Contact: Corinne Williams
Journal of Clinical Investigation

Public Release: 20-Oct-2015
JAMA Oncology
Menopausal status a better indicator than age for mammography frequency
In a study conducted to inform American Cancer Society breast cancer screening guidelines, UC Davis researcher Diana L. Miglioretti reports a screening mammogram once every two years is safe for postmenopausal women at average risk of breast cancer.
American Cancer Society

Contact: Dorsey Griffith
University of California - Davis Health System

Public Release: 20-Oct-2015
Molecular Cell
A new way to starve lung cancer?
Scientists have identified a new way to stop the growth of lung cancer cells, by blocking their ability to use alternative sources of nutrition. The discovery was made possible by identifying the metabolic programs used by cancer cells to fuel their growth. The findings point to possible new avenues for treating lung cancer, which is the second most common cancer and accounts for over one-quarter of all cancer-related deaths. The results of the study were published Oct. 15 in the journal Molecular Cell.

Contact: Cynthia Lee
McGill University

Public Release: 20-Oct-2015
JAMA Oncology
Annual vs. biennial mammography and breast tumor prognostic characteristics
Premenopausal women diagnosed with breast cancer following a biennial screening mammogram were more likely to have bigger more advanced tumors than women screened annually, while postmenopausal women not using hormone therapy had a similar proportion of tumors with less favorable prognostic characteristics regardless of whether their screening mammogram was biennial or annual, according to an article published online by JAMA Oncology.

Contact: Dorsey Griffith
The JAMA Network Journals

Public Release: 20-Oct-2015
Journal of Clinical Aesthetics and Dermatology
VivoSight OCT scanner significantly improves early-stage diagnosis of basal cell carcinoma
Recent data shows that the VivoSight OCT scanner significantly improves diagnosis of basal-cell carcinoma at an earlier stage and reduces diagnostic biopsies by 36 percent.
Michelson Diagnostics

Contact: Mike Sinclair
Halsin Partners

Public Release: 20-Oct-2015
Later age recommended for first screening mammogram
Among the changes in the American Cancer Society's updated breast cancer screening guideline is that women with an average risk of breast cancer should undergo regular, annual screening mammography beginning at age 45 years, with women having an opportunity to choose to begin annual screening as early as age 40; and women 55 years and older should transition to screening every other year (vs. annual), according to an article in the Oct. 20 issue of JAMA.

Contact: David Sampson
The JAMA Network Journals

Public Release: 20-Oct-2015
Study provides more precise estimates of cancer risks associated with low level radiation
More precise estimates of cancer risks associated with prolonged, low level exposure to ionising radiation among nuclear industry workers are published by The BMJ today.

Contact: Emma Dickinson

Public Release: 20-Oct-2015
RSA Adv.
UGR scientists patent an effective drug for treating breast, colon, and skin cancers
The new compound reduced the tumour activity by 50 percent following 41 days of treatment, in mice with induced tumors. The drug is non-toxic and can be produced cheaply and quickly. The research project recently received €124,930 of public sector funding from the Ministry of Economy and Finance and the firm Canvax Biotech SL and €20,000 from the private sector.

Contact: Joaquín Campos Rosa
University of Granada

Public Release: 19-Oct-2015
Nature Cell Biology
Orange lichens are potential source for anticancer drugs
An orange pigment found in lichens and rhubarb called parietin may have potential as an anti-cancer drug because it interferes with the metabolic enzyme 6PGD, scientists at Winship Cancer Institute of Emory University have discovered.
NIH/National Cancer Institute, US Department of Defense

Contact: Quinn Eastman
Emory Health Sciences

Public Release: 19-Oct-2015
Proceedings of the National Academy of Sciences
TSRI scientists find way to make leukemia cells kill each other
Scientists at The Scripps Research Institute have found a way to change leukemia cells into leukemia-killing immune cells. The surprise finding could lead to a powerful new therapy for leukemia and possibly other cancers.
JPB Foundation, Zebra Biologics

Contact: Mika Ono
Scripps Research Institute

Public Release: 19-Oct-2015
Journal of the National Cancer Institute
Risks of LDCT LC screenings need to be assessed in 20- to 29-pack-year smokers
The potential risks and harms of low-dose CT (LDCT) lung cancer screening in current 20- to 29-pack-year smokers needs to be assessed before recommending LDCT to this group, according to a study published Oct. 19 in the JNCI: Journal of the National Cancer Institute.

Contact: Zachary Rathner
Oxford University Press USA

Public Release: 19-Oct-2015
Proceedings of the National Academy of Sciences
Gene on-off switch works like backpack strap
A research team based in Houston's Texas Medical Center has found that loop-forming proteins inside the human chromosome appear to work like the sliding plastic adjusters on a grade-schooler's backpack. This discovery may allow researchers to reprogram human cells by directly modifying the loops that form in DNA.
Welch Foundation, IBM, Nvidia, National Science Foundation, National Institutes of Health, Cancer Prevention and Research Institute of Texas, McNair Medical Institute

Contact: Jade Boyd
Rice University

Public Release: 19-Oct-2015
British Journal of Dermatology
More than 11 moles on your arm could indicate higher risk of melanoma
Researchers at King's College London have investigated a new method that could be used by GPs to quickly determine the number of moles on the entire body by counting the number found on a smaller 'proxy' body area, such as an arm.
Wellcome Trust

Contact: Hannah Pluthero
King's College London

Public Release: 19-Oct-2015
American Society for Radiation Oncology's 57th Annual Meeting
For low-risk prostate cancer a shortened RT schedule has similar benefit
Clinical trial results presented today at the ASTRO plenary session confirm that patients with low-risk prostate cancer can be treated with a shortened (or hypofractionated) course of radiotherapy and experience the same level of cancer control as those treated with a conventional course of radiotherapy.

Contact: Nancy Fredericks
NRG Oncology

Public Release: 19-Oct-2015
CHEST Annual Meeting 2015
Patients undergoing lung cancer screening experience elevated levels of distress
Low-dose computed tomography lung cancer screening is recommended to screen patients with an increased risk of developing lung cancer, but little research regarding the emotional toll of screening has been conducted. Researchers from Stony Brook Cancer Center in Stony Brook, New York found 43 percent of patients undergoing LDCT experienced elevated distress before screening, and one-third of patients experienced continued distress even after being told there was no sign of cancer.

Contact: Kristi Bruno
American College of Chest Physicians

Public Release: 19-Oct-2015
'Reversible' tumor suppressor loss: Key to new brain cancer therapies?
It's no surprise that people enjoy warm places like Hawaii but may suffer in hostile locales such as Antarctica. A tumor suppressor gene called PTEN is similar in that it is affected by the microenvironments of certain bodily organs to which it travels.

Contact: Ron Gilmore
University of Texas M. D. Anderson Cancer Center

Public Release: 19-Oct-2015
American Society for Radiation Oncology's 57th Annual Meeting
ASTRO: Penn Medicine studies point to clinical advantages of proton therapy
New data from clinical trials conducted at the Robert Proton Therapy Center demonstrate the technology's potential advantages over conventional radiation, including less side effects and survival in some cases, for several harder-to-treat tumors: pancreatic, late-stage, non-small cell lung and chordoma and chondrosarcoma, two rare cancers found in bone or soft tissue.

Contact: Steve Graff
University of Pennsylvania School of Medicine

Public Release: 19-Oct-2015
Study shows outreach increases completion of HPV vaccination series by adolescent girls
A joint study by UT Southwestern Medical Center and Parkland Health & Hospital System investigators found that a multicomponent outreach program increased completion of the three-dose human papillomavirus (HPV) vaccination series that reduces the risk of cervical cancer caused by the virus.
Cancer Prevention and Research Institute of Texas

Contact: Lori Sundeen Soderbergh
UT Southwestern Medical Center

Public Release: 19-Oct-2015
American Society for Radiation Oncology Annual Meeting
24 months of ATT improves survival for men with cancer recurrence after prostatectomy
For men diagnosed with prostate cancer and treated with radical prostatectomy, adding 24 months of anti-androgen therapy during and after salvage radiotherapy improves overall survival compared with salvage RT treatment alone, according to results of a clinical trial conducted by the Radiation Therapy Oncology Group now NRG Oncology. The RTOG 9601 study results also reveal that the addition of ATT to salvage RT reduces prostate cancer death and the development of metastatic prostate cancer.

Contact: Nancy Fredericks
NRG Oncology

Public Release: 18-Oct-2015
American Society for Radiation Oncology's 57th Annual Meeting
For lung cancer patients, IMRT associated with lesser side effects, better tolerance of chemotherapy, compared to conventional radiation therapy
An analysis of an international, cooperative-led trial of patients with locally advanced non-small cell lung cancer has shown that those who received intensity modulated radiation therapy had less severe lung toxicity and were able to better tolerate their chemotherapy, compared to patients who received 3-D conformal radiation therapy.

Contact: Laura Sussman
University of Texas M. D. Anderson Cancer Center

Public Release: 16-Oct-2015
Blood Cancer Journal
Scientists find evidence of how incurable cancer develops
Researchers have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder. The findings could lead to more effective treatments and ways to identify those most at risk of developing the cancer.

Contact: Luke Harrison
University of Birmingham

Public Release: 16-Oct-2015
Discovery opens door to new strategy for cancer immunotherapy
New research by Dana-Farber Cancer Institute scientists raises the prospect of cancer therapy that works by converting a tumor's best friends in the immune system into its gravest enemies.
LeRoy Schecter Research Foundation, National Institutes of Health, Arthritis National Research Foundation

Contact: Anne Doerr
Dana-Farber Cancer Institute

Public Release: 16-Oct-2015
Cell Reports
The CNIO discovers a link between a rare form of anemia and cancer
More than 20 percent of people affected by Diamond-Blackfan anemia, a rare disease, develop various types of tumors throughout their lives. CNIO researchers have created the first animal model with this type of anemia that also recapitulates the predisposition to cancer. The finding, published in the journal Cell Reports, could potentially improve current treatments for this type of anemia, which, to date, are only effective in resolving the hematological disorders.

Contact: Vanessa Pombo
Centro Nacional de Investigaciones Oncologicas (CNIO)

Public Release: 16-Oct-2015
Cancer Cell
Protein found in malaria could help stop cancer
Researchers at the Translational Genomics Research Institute joined an international team of scientists in discovering how a protein from malaria could some day help stop cancer.

Contact: Steve Yozwiak
The Translational Genomics Research Institute

Public Release: 15-Oct-2015
Scientists produce clearest-ever images of enzyme that plays key roles in aging, cancer
The telomerase enzyme is known to play a significant role in aging and most cancers. A team of UCLA and UC Berkeley scientists reports several major new insights about this enzyme in the Oct. 15 online edition of the journal Science and the researchers are now able to see the complex enzyme's sub-units in much sharper resolution than ever.

Contact: Stuart Wolpert
University of California - Los Angeles

Showing releases 276-300 out of 1253.

<< < 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 > >>

  Search News Releases